A detailed history of Wellington Shields & Co., LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wellington Shields & Co., LLC holds 78,402 shares of PFE stock, worth $2.09 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
78,402
Previous 77,794 0.78%
Holding current value
$2.09 Million
Previous $2.18 Million 4.23%
% of portfolio
0.71%
Previous 0.72%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $16,841 - $19,085
608 Added 0.78%
78,402 $2.27 Million
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $93,638 - $109,727
3,707 Added 5.0%
77,794 $2.18 Million
Q1 2024

May 23, 2024

BUY
$25.89 - $29.73 $46,809 - $53,751
1,808 Added 2.5%
74,087 $2.06 Million
Q1 2024

May 23, 2024

SELL
$25.89 - $29.73 $46,809 - $53,751
-1,808 Reduced 2.44%
72,279 $2.01 Million
Q1 2024

May 03, 2024

BUY
$25.89 - $29.73 $46,809 - $53,751
1,808 Added 2.5%
74,087 $2.06 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $29,396 - $38,182
-1,125 Reduced 1.53%
72,279 $2.08 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $448,104 - $523,789
13,964 Added 23.49%
73,404 $2.43 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $475,230 - $549,831
-13,157 Reduced 18.12%
59,440 $2.18 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $80,946 - $105,380
2,055 Added 2.91%
72,597 $2.96 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $16,533 - $21,582
396 Added 0.56%
70,542 $3.62 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $64,502 - $78,741
1,474 Added 2.15%
70,146 $3.07 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $757,229 - $897,836
-16,274 Reduced 19.16%
68,672 $3.6 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $241,697 - $299,493
5,283 Added 6.63%
84,946 $4.4 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $100,118 - $148,408
2,423 Added 3.14%
79,663 $4.7 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $12,756 - $16,386
325 Added 0.42%
77,240 $3.32 Million
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $19,858 - $22,496
553 Added 0.72%
76,915 $3.01 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $50,402 - $56,843
1,505 Added 2.01%
76,362 $2.77 Million
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $28,750 - $36,559
-859 Reduced 1.13%
74,857 $2.76 Million
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $35,972 - $42,204
1,133 Added 1.52%
75,716 $2.78 Million
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $4,156 - $5,042
138 Added 0.19%
74,583 $2.44 Million
Q1 2020

May 07, 2020

BUY
$27.03 - $38.62 $17,326 - $24,755
641 Added 0.87%
74,445 $2.43 Million
Q4 2019

Feb 11, 2020

BUY
$32.92 - $37.36 $1.81 Million - $2.06 Million
55,006 Added 292.62%
73,804 $2.89 Million
Q3 2019

Nov 05, 2019

SELL
$32.49 - $42.13 $1.78 Million - $2.31 Million
-54,758 Reduced 74.44%
18,798 $675,000
Q2 2019

Aug 08, 2019

SELL
$36.98 - $41.52 $7,654 - $8,594
-207 Reduced 0.28%
73,556 $3.19 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $18,600 - $20,435
-496 Reduced 0.67%
73,763 $3.13 Million
Q4 2018

Feb 11, 2019

BUY
$38.47 - $43.86 $722,889 - $824,173
18,791 Added 33.88%
74,259 $3.24 Million
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $58,633 - $71,118
1,701 Added 3.16%
55,468 $2.44 Million
Q2 2018

Aug 02, 2018

SELL
$32.98 - $35.16 $2,836 - $3,023
-86 Reduced 0.16%
53,767 $1.95 Million
Q1 2018

May 03, 2018

BUY
$31.91 - $37.02 $3,637 - $4,220
114 Added 0.21%
53,853 $0
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $117,906 - $125,103
-3,545 Reduced 6.19%
53,739 $1.95 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $1.78 Million - $1.96 Million
57,284
57,284 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wellington Shields & Co., LLC Portfolio

Follow Wellington Shields & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.